Sunway Healthcare 2Q Net Profit Jumps To RM78.15 Mln

KUALA LUMPUR, Aug 20 (Bernama) -- Sunway Healthcare Holdings Bhd’s net profit for the second quarter of the financial year ending Dec 31, 2026 (2Q 2026) leapt to RM78.15 million from RM41.38 million a year earlier.

Revenue also increased 30 per cent to RM672.89 million from RM518.57 million previously, mainly driven by higher contributions from the hospital operations segment.

In a filing with Bursa Malaysia, the company said the hospital operations segment recorded revenue of RM659.2 million in the current quarter, up from RM510.5 million in the corresponding quarter of the previous financial period, an increase of 29 per cent.

“The growth was mainly attributable to higher patient volumes across the group’s hospitals, as well as increased revenue contributions from Sunway Medical Centre (SMC) Sunway City, Damansara and Ipoh.

“Foreign patient revenue increased by 31 per cent to RM84.9 million, from RM65.0 million in the corresponding quarter of the previous financial year.

“The growth was primarily driven by higher patient inflows from Indonesia, China and Cambodia,” it added.

Sunway Healthcare also noted that the group’s overall bed occupancy rate for 2Q 2026 was 73 per cent, up from 67 per cent in the previous corresponding quarter.

“In 2Q 2026, its inpatient admissions in the hospital operations segment increased by 19 per cent to 32,599,” it said.

For the six months ended June 30, 2026 (6M 2026), the group’s net profit rose to RM111.48 million compared with RM80.13 million, while revenue also edged up to RM1.25 billion from RM992,623 million, previously.

No dividend has been proposed by the board of directors for the financial period ended June 30, 2026.

On prospects, the group said it will continue preparing for the planned MediAsas rollout and the phased implementation of the Diagnosis-Related Group payment framework, while engaging insurers and takaful operators on sustainable reimbursement arrangements.

“The group will continue to broaden its foreign patient source markets, referral channels and payor partnerships, while maintaining diversified sourcing, adequate inventory buffers and disciplined cost management.

“It will also focus on converting patient-volume growth and capacity activation into sustainable earnings while preserving accessibility, clinical excellence, operational resilience and financial discipline,” it said.

-- BERNAMA